NCT01245803

Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS

Acute Rosuvastatin for Preventing Myocardial Damage in Patients With Acute Coronary Syndrome

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 400 (estimated)
• Sponsor: Beijing Anzhen Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Rosuvastatin reload may prevent myocardial damage in ACS patients undergoing PCI

Conditions

• Acute Coronary Syndrome
• Angioplasty

Interventions

Type	Name	Description
DRUG	additional rosuvastatin loading	additional rosuvastatin (10mg p.o.)is given at 18 hours and 4-6 hours before PCI
DRUG	placebo control	sugar pill is given 18-24hr and 4-6hr before PCI as control

Timeline

• Start date: 2010-04-01
• Primary completion: 2011-04-01
• Completion: 2011-05-01
• First posted: 2010-11-23
• Last updated: 2010-11-23

Locations

1 site across 1 country: China